164 related articles for article (PubMed ID: 37035213)
1. LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4.
Li J; Yuan X; Ma C; Li J; Qu G; Yu B; Cai F; Peng Y; Liu L; Zeng D; Jiao Q; Zhang J; Luo X; Liao Q; Lv XB
Front Oncol; 2023; 13():1139588. PubMed ID: 37035213
[TBL] [Abstract][Full Text] [Related]
2. LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer.
Yang Z; Dong X; Pu M; Yang H; Chang W; Ji F; Liu T; Wei C; Zhang X; Qiu X
Gastric Cancer; 2020 May; 23(3):449-463. PubMed ID: 31673844
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma.
Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LBX2-AS1 enhances glioma proliferation through downregulating microRNA-491-5p.
Chen Q; Gao J; Zhao Y; Hou R
Cancer Cell Int; 2020; 20():411. PubMed ID: 32863770
[TBL] [Abstract][Full Text] [Related]
5. LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.
Cao J; Wang H; Liu G; Tang R; Ding Y; Xu P; Wang H; Miao J; Gu X; Han S
J Cell Mol Med; 2021 Jan; 25(2):1178-1189. PubMed ID: 33342041
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LBX2-AS1 promotes proliferation and migratory capacity of clear cell renal cell carcinoma through mitophagy.
Wang B; Wei Y; Han T; Ji P; Miao H; Wu X; Qian J; Shao P
Eur J Med Res; 2024 Feb; 29(1):103. PubMed ID: 38326905
[TBL] [Abstract][Full Text] [Related]
9. SP1-upregulated LBX2-AS1 promotes the progression of glioma by targeting the miR-491-5p/LIF axis.
Li W; Soufiany I; Lyu X; Lu C; Wei Y; Shi Z; You Y
J Cancer; 2021; 12(23):6989-7002. PubMed ID: 34729101
[No Abstract] [Full Text] [Related]
10. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
12. Long-non-coding RNA RUSC1-AS1 accelerates osteosarcoma development by miR-101-3p-mediated Notch1 signalling pathway.
Jiang R; Zhang Z; Zhong Z; Zhang C
J Bone Oncol; 2021 Oct; 30():100382. PubMed ID: 34367901
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LBX2-AS1-modulated miR-4766-5p regulates gastric cancer development through targeting CXCL5.
Peng L; Chen Z; Wang G; Tian S; Kong S; Xu T; An X; Chen Y
Cancer Cell Int; 2020; 20():497. PubMed ID: 33061849
[TBL] [Abstract][Full Text] [Related]
14. LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p.
Su YZ; Cui MF; Du J; Song B
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1158-1167. PubMed ID: 32096164
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LBX2-AS1 inhibits acute myeloid leukemia progression through miR-455-5p/MYLIP axis.
Fu G; Wu H; Wu X; Yang Y; Fan C
Heliyon; 2024 Jan; 10(2):e24812. PubMed ID: 38312562
[TBL] [Abstract][Full Text] [Related]
16. Silencing of lncRNA KLF3-AS1 represses cell growth in osteosarcoma via miR-338-3p/MEF2C axis.
Chen C; Liu L
J Clin Lab Anal; 2022 Nov; 36(11):e24698. PubMed ID: 36250223
[TBL] [Abstract][Full Text] [Related]
17. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
Chen S; Li K
BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
[TBL] [Abstract][Full Text] [Related]
18. Silencing of lncRNA LBX2-AS1 suppresses glioma cell proliferation and metastasis through the Akt/GSK3β pathway in vitro.
Wen H; Li Z; Song S; Xu L; Tong X; Yan H
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):446-453. PubMed ID: 33637977
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
Si Z; Yu L; Jing H; Wu L; Wang X
J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA OIP5-AS1 Knockdown Enhances CDDP Sensitivity in Osteosarcoma via miR-377-3p/FOSL2 Axis.
Liu L; Wang S
Onco Targets Ther; 2020; 13():3853-3866. PubMed ID: 32440152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
